Hemophilia B

The FDA approved a new method of administering treatment for patients with wet age-related macular degeneration and macular edema following retinal vein occlusion.

The FDA approved a new method of administering treatment for patients with wet age-related macular degeneration and macular edema following retinal vein occlusion.

The FDA has approved a quadrivalent formulation of Flublok influenza vaccine, which protects against 4 strains of influenza.

The FDA has approved a quadrivalent formulation of Flublok influenza vaccine, which protects against 4 strains of influenza.

The FDA has approved a quadrivalent formulation of Flublok influenza vaccine, which protects against 4 strains of influenza.

The FDA has approved Zubsolv (buprenorphine/naloxone CIII sublingual tablets) 0.7mg/0.18mg for the treatment of patients with opioid dependence.

The FDA has approved Zubsolv (buprenorphine/naloxone CIII sublingual tablets) 0.7mg/0.18mg for the treatment of patients with opioid dependence.

The FDA has approved Zubsolv (buprenorphine/naloxone CIII sublingual tablets) 0.7mg/0.18mg for the treatment of patients with opioid dependence.

The US Food and Drug Administration is now requiring a Boxed Warning be added to the drug labels of certain direct-acting antiviral medicines used for the treatment of hepatitis C.

The FDA issued a statement regarding serious adverse events with homeopathic teething tablets and gels.